We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+14.45%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$43.5B
AUM Growth
+$6.37B
(+17%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
9.32%
Holding
3,484
New
550
Increased
1,237
Reduced
1,116
Closed
366
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INBX
2651
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $300K | ﹤0.01% |
7,900
-199,770
| -96% | -$4.28M |
|
2652
Victory Capital Holdings
VCTR
$6.65B
| $300K | ﹤0.01% |
+8,700
| New | +$278K |
|
2653
Republic Bancorp
RBCAA
$1.95B
| $299K | ﹤0.01% |
5,419
-4,045
| -43% | -$193K |
|
|
ITOS
2654
DELISTED
iTeos Therapeutics
ITOS
| $298K | ﹤0.01% |
+27,217
| New | +$270K |
|
2655
Silicom
SILC
$242M
| $298K | ﹤0.01% |
+16,458
| New | +$303K |
|
2656
First Mid Bancshares
FMBH
$1.36B
| $296K | ﹤0.01% |
8,546
-12,772
| -60% | -$386K |
|
2657
Bankwell Financial Group
BWFG
$533M
| $294K | ﹤0.01% |
9,731
-4,522
| -32% | -$120K |
|
2658
Middlesex Water
MSEX
$1.1B
| $294K | ﹤0.01% |
4,473
+673
| +18% | +$44.4K |
|
2659
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$604M
| $293K | ﹤0.01% |
+4,300
| New | +$264K |
|
|
MACK
2660
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $293K | ﹤0.01% |
+21,834
| New | +$276K |
|
2661
UFP Technologies
UFPT
$2.43B
| $292K | ﹤0.01% |
1,700
-5,409
| -76% | -$876K |
|
|
OKUR
2662
OnKure Therapeutics
OKUR
$168M
| $292K | ﹤0.01% |
+18,247
| New | +$1.14M |
|
2663
Acacia Research
ACTG
$470M
| $289K | ﹤0.01% |
+73,822
| New | +$273K |
|
2664
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
| $288K | ﹤0.01% |
+3,010
| New | +$245K |
|
2665
OmniAb
OABI
$447M
| $287K | ﹤0.01% |
46,584
+4,884
| +12% | +$24K |
|
2666
Abeona Therapeutics
ABEO
$413M
| $285K | ﹤0.01% |
+56,948
| New | +$251K |
|
2667
Harvard Bioscience
HBIO
$29.2M
| $285K | ﹤0.01% |
5,324
-7,778
| -59% | -$351K |
|
|
BPT
2668
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $285K | ﹤0.01% |
+115,197
| New | +$468K |
|
2669
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.83B
| $284K | ﹤0.01% |
+1,800
| New | +$259K |
|
2670
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.89B
| $283K | ﹤0.01% |
3,200
-6,500
| -67% | -$511K |
|
2671
Stoneridge
SRI
$213M
| $283K | ﹤0.01% |
14,436
+1,309
| +10% | +$22.7K |
|
2672
Phinia Inc
PHIN
$2.74B
| $282K | ﹤0.01% |
+9,300
| New | +$249K |
|
|
DRD
2673
DRDGold
DRD
$2.05B
| $281K | ﹤0.01% |
35,400
-21,563
| -38% | -$185K |
|
2674
VanEck Semiconductor ETF
SMH
$73.2B
| $280K | ﹤0.01% |
1,600
-1,137,100
| -100% | -$178M |
|
2675
Northwest Natural Holdings
NWN
$2.12B
| $278K | ﹤0.01% |
7,130
+530
| +8% | +$20.1K |
|
Similar funds
VAM
Two Sigma Investments's Q4 2023 Portfolio in Review
As of Q4 2023, Two Sigma Investments held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Two Sigma Investments's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- Two Sigma Investments's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- Two Sigma Investments's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- Two Sigma Investments fully exited Tesla in Q4 2023, selling an estimated $254M.
- Two Sigma Investments's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- Two Sigma Investments opened 550 new positions and closed 366 in Q4 2023.
- Two Sigma Investments's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.